These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9621917)
21. A comparison of conventional and fast spin-echo sequences for the measurement of lesion load in multiple sclerosis using a semi-automated contour technique. Rovaris M; Gawne-Cain ML; Wang L; Miller DH Neuroradiology; 1997 Mar; 39(3):161-5. PubMed ID: 9106285 [TBL] [Abstract][Full Text] [Related]
22. Segmentation of gadolinium-enhanced lesions on MRI in multiple sclerosis. Datta S; Sajja BR; He R; Gupta RK; Wolinsky JS; Narayana PA J Magn Reson Imaging; 2007 May; 25(5):932-7. PubMed ID: 17457804 [TBL] [Abstract][Full Text] [Related]
23. Activity revealed in MRI of multiple sclerosis without contrast agent. A preliminary report. Horsfield MA; Rocca MA; Cercignani M; Filippi M Magn Reson Imaging; 2000 Feb; 18(2):139-42. PubMed ID: 10722973 [TBL] [Abstract][Full Text] [Related]
24. Automated segmentation of multiple sclerosis lesions by model outlier detection. Van Leemput K; Maes F; Vandermeulen D; Colchester A; Suetens P IEEE Trans Med Imaging; 2001 Aug; 20(8):677-88. PubMed ID: 11513020 [TBL] [Abstract][Full Text] [Related]
25. MRI measurement of brain tumor response: comparison of visual metric and automatic segmentation. Clarke LP; Velthuizen RP; Clark M; Gaviria J; Hall L; Goldgof D; Murtagh R; Phuphanich S; Brem S Magn Reson Imaging; 1998 Apr; 16(3):271-9. PubMed ID: 9621968 [TBL] [Abstract][Full Text] [Related]
26. Adaptive multi-level conditional random fields for detection and segmentation of small enhanced pathology in medical images. Karimaghaloo Z; Arnold DL; Arbel T Med Image Anal; 2016 Jan; 27():17-30. PubMed ID: 26211811 [TBL] [Abstract][Full Text] [Related]
27. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Kermode AG; Thompson AJ; Tofts P; MacManus DG; Kendall BE; Kingsley DP; Moseley IF; Rudge P; McDonald WI Brain; 1990 Oct; 113 ( Pt 5)():1477-89. PubMed ID: 2245307 [TBL] [Abstract][Full Text] [Related]
28. Multiple sclerosis lesion quantification using fuzzy-connectedness principles. Udupa JK; Wei L; Samarasekera S; Miki Y; van Buchem MA; Grossman RI IEEE Trans Med Imaging; 1997 Oct; 16(5):598-609. PubMed ID: 9368115 [TBL] [Abstract][Full Text] [Related]
29. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Larsson HB; Stubgaard M; Frederiksen JL; Jensen M; Henriksen O; Paulson OB Magn Reson Med; 1990 Oct; 16(1):117-31. PubMed ID: 2255233 [TBL] [Abstract][Full Text] [Related]
30. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. Lai M; Hodgson T; Gawne-Cain M; Webb S; MacManus D; McDonald WI; Thompson AJ; Miller DH J Neurol Neurosurg Psychiatry; 1996 Mar; 60(3):339-41. PubMed ID: 8609517 [TBL] [Abstract][Full Text] [Related]
31. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine. Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648 [TBL] [Abstract][Full Text] [Related]
32. [A New Method to Segment Multiple Sclerosis Lesions Using Multispectral Magnetic Resonance Images]. Xiang Y; He J; Ma L; Xu J Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Apr; 32(2):330-5. PubMed ID: 26211250 [TBL] [Abstract][Full Text] [Related]
33. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773 [TBL] [Abstract][Full Text] [Related]
34. Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification. Miki Y; Grossman RI; Udupa JK; Samarasekera S; van Buchem MA; Cooney BS; Pollack SN; Kolson DL; Constantinescu C; Polansky M; Mannon LJ AJNR Am J Neuroradiol; 1997 Apr; 18(4):705-10. PubMed ID: 9127034 [TBL] [Abstract][Full Text] [Related]
35. Short-term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium-enhanced brain MRI scans. Rovaris M; Mastronardo G; Prandini F; Bastianello S; Comi G; Filippi M J Neurol Sci; 1999 Apr; 164(2):148-52. PubMed ID: 10402026 [TBL] [Abstract][Full Text] [Related]
36. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent. Bagnato F J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471 [No Abstract] [Full Text] [Related]
37. [Diffusion-weighted magnetic resonance tomography in diagnosis of encephalitis disseminata]. Hagen T; Schweigerer-Schröter G; Wellnitz J; Würstle T Radiologe; 2000 Nov; 40(11):1057-63. PubMed ID: 11147321 [TBL] [Abstract][Full Text] [Related]
38. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628 [TBL] [Abstract][Full Text] [Related]